1. Pan-cancer molecular analysis of the RB tumor suppressor pathway
- Author
-
Dominic J. Smiraglia, David W. Goodrich, Spencer Rosario, Erik S. Knudsen, Ram Nambiar, and Agnieszka K. Witkiewicz
- Subjects
0301 basic medicine ,Tumor suppressor gene ,Retinal Neoplasms ,Ubiquitin-Protein Ligases ,Medicine (miscellaneous) ,Locus (genetics) ,Biology ,General Biochemistry, Genetics and Molecular Biology ,Article ,law.invention ,03 medical and health sciences ,0302 clinical medicine ,law ,Gene expression ,Databases, Genetic ,medicine ,Biomarkers, Tumor ,Cancer genomics ,Humans ,Tumour-suppressor proteins ,Gene ,Cancer genetics ,lcsh:QH301-705.5 ,Cell Proliferation ,Pan cancer ,Chromosomes, Human, Pair 13 ,Retinoblastoma ,Gene Expression Profiling ,Cyclin-Dependent Kinase 4 ,Cyclin-Dependent Kinase 6 ,medicine.disease ,Prognosis ,Molecular analysis ,Gene Expression Regulation, Neoplastic ,Retinoblastoma Binding Proteins ,030104 developmental biology ,lcsh:Biology (General) ,030220 oncology & carcinogenesis ,Cancer research ,Disease Progression ,Suppressor ,General Agricultural and Biological Sciences ,Transcriptome ,Signal Transduction - Abstract
The retinoblastoma tumor suppressor gene (RB1) plays a critical role in coordinating multiple pathways that impact cancer initiation, disease progression, and therapeutic responses. Here we probed molecular features associated with the RB-pathway across 31 tumor-types. While the RB-pathway has been purported to exhibit multiple mutually exclusive genetic events, only RB1 alteration is mutually exclusive with deregulation of CDK4/6 activity. An ER+ breast cancer model with targeted RB1 deletion was used to identify signatures of CDK4/6 activity and RB-dependency (CDK4/6-RB integrated signature). This signature was prognostic in tumor-types with gene expression features indicative of slower growth. Single copy loss on chromosome 13q encompassing the RB1 locus is prevalent in many cancers, yielding reduced expression of multiple genes in cis, and is inversely related to the CDK4/6-RB integrated signature supporting a cause-effect relationship. Genes that are positively and inversely correlated with the CDK4/6-RB integrated signature define new tumor-specific pathways associated with RB-pathway activity., Erik Knudsen et al. present a pan-cancer analysis of the RB tumor suppressor protein pathway in 31 tumor types. They find that pathway deregulation is multi-faceted with context dependent association with survival. However, gene expression features are surprisingly invariant and support new therapeutic targets.
- Published
- 2020